BioSpace News Archive

Press Releases

OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma

November 18, 2025
·
6 min read
Press Releases

LUPRON DEPOT® new strength receives Health Canada Approval for the Treatment of Advanced Prostate Cancer

November 18, 2025
·
4 min read
Press Releases

Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study

November 18, 2025
·
7 min read
Press Releases

Aclipse Therapeutics to Collaborate with Mayo Clinic on Phase 2 Clinical Development of M107 for the Treatment of Gastroparesis

November 18, 2025
·
2 min read
Press Releases

ReCode Therapeutics Initiates Enrollment of Phase 2 Clinical Trial of RCT2100 in Combination with Ivacaftor for the Treatment of Cystic Fibrosis

November 18, 2025
·
3 min read
Press Releases

AdvanCell Appoints Philina Lee, PhD as Chief Executive Officer to Lead US Expansion and Drive Global Growth

November 18, 2025
·
4 min read
Press Releases

OraSure to Participate in Upcoming November 2025 Investor Conference

November 18, 2025
·
1 min read
Press Releases

Plus Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement

November 18, 2025
·
4 min read
Press Releases

Medicus Pharma Ltd. Announces Filing of FDA Commissioner’s National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

November 18, 2025
·
17 min read
Press Releases

Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue

November 18, 2025
·
11 min read